Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Assets: 2010-2024

Historic Assets for Heron Therapeutics (HRTX) over the last 12 years, with Dec 2024 value amounting to $233.1 million.

  • Heron Therapeutics' Assets rose 12.76% to $248.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $248.9 million, marking a year-over-year increase of 12.76%. This contributed to the annual value of $233.1 million for FY2024, which is 4.78% up from last year.
  • Heron Therapeutics' Assets amounted to $233.1 million in FY2024, which was up 4.78% from $222.5 million recorded in FY2023.
  • In the past 5 years, Heron Therapeutics' Assets registered a high of $353.6 million during FY2020, and its lowest value of $222.5 million during FY2023.
  • For the 3-year period, Heron Therapeutics' Assets averaged around $235.5 million, with its median value being $233.1 million (2024).
  • Per our database at Business Quant, Heron Therapeutics' Assets plummeted by 31.05% in 2020 and then grew by 4.78% in 2024.
  • Over the past 5 years, Heron Therapeutics' Assets (Yearly) stood at $353.6 million in 2020, then declined by 13.53% to $305.7 million in 2021, then fell by 17.91% to $251.0 million in 2022, then decreased by 11.33% to $222.5 million in 2023, then rose by 4.78% to $233.1 million in 2024.